Neha Krishnamohan serves as Executive at Kinnate Biopharma Inc., where they oversee executive responsibilities. Since joining the company, Neha Krishnamohan has executed 18 insider transactions totaling $939.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 15, 2025 involved selling 3,490 shares valued at $11.3K.
Neha Krishnamohan currently holds 99,356 shares of Kinnate Biopharma Inc. (KNTE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Neha Krishnamohan has been a net seller of KNTE stock. They have purchased $0 and sold $939.5K worth of shares.
Neha Krishnamohan's most recent insider trade was on Nov 15, 2025, when they sold 3,490 shares at $3.25 per share.
Get notified when new Form 4 filings are submitted
| 27,052 |
| $8.63 |
| Discretionary |
| Nov 13, 2025 | ARQT | $91.8K | Option Exercise | 12,220 | $7.51 | Discretionary |
| Nov 13, 2025 | ARQT | $910.7K | Sale | 39,272 | $23.19 | Discretionary |
| Nov 13, 2025 | ARQT | $28.8K | Sale | 1,232 | $23.37 | Discretionary |
| Aug 15, 2025 | ARTV | $16.0K | Payment | 5,813 | $2.75 | Discretionary |
| May 15, 2025 | ARTV | $2.9K | Payment | 1,341 | $2.13 | Discretionary |
| Sep 12, 2024 | ARTV | $0 | Award | 50,000 | $N/A | Discretionary |
| Jun 14, 2024 | ARQT | $0 | Award | 10,139 | $N/A | Discretionary |
| Apr 3, 2024 | KNTE | $0 | Disposition | 64,087 | $N/A | Discretionary |
| Mar 1, 2024 | KNTE | $3.9K | Payment | 1,506 | $2.59 | Discretionary |
| Dec 1, 2023 | KNTE | $3.3K | Payment | 1,459 | $2.25 | Discretionary |
| Sep 1, 2023 | KNTE | $3.4K | Payment | 1,459 | $2.35 | Discretionary |
| Jun 1, 2023 | KNTE | $6.3K | Payment | 1,459 | $4.30 | Discretionary |
| May 31, 2023 | ARQT | $0 | Award | 4,375 | $N/A | Discretionary |
| Mar 1, 2023 | KNTE | $9.0K | Payment | 1,721 | $5.21 | Discretionary |
| Dec 1, 2022 | KNTE | $11.3K | Payment | 1,459 | $7.75 | Discretionary |
| Sep 1, 2022 | KNTE | $0 | Award | 67,500 | $N/A | Discretionary |